Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 271 citing articles:

Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Saranya Chidambaranathan Reghupaty, Paul B. Fisher, Devanand Sarkar
Advances in cancer research (2020), pp. 1-61
Open Access | Times Cited: 637
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 382
Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 305
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Benjamin Ruf, Bernd Heinrich, Tim F. Greten
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 112-127
Open Access | Times Cited: 238
Single-cell genomics and spatial transcriptomics: Discovery of novel cell states and cellular interactions in liver physiology and disease biology
Antonio Saviano, Neil C. Henderson, Thomas F. Baumert
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1219-1230
Open Access | Times Cited: 214
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
Julie Giraud, Domitille Chalopin, Jean‐Frédéric Blanc, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 174
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
Yongxiang Xia, Weiwei Tang, Xiaofeng Qian, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004656-e004656
Open Access | Times Cited: 145
IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment
Bo Hu, Mincheng Yu, Xiaolu Ma, et al.
Cancer Discovery (2022) Vol. 12, Iss. 7, pp. 1718-1741
Open Access | Times Cited: 133
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
Phuong H. D. Nguyen, Siming Ma, Cheryl Zi Jin Phua, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
Charlotte K.Y. Ng, Eva Dazert, Tuyana Boldanova, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 109
High-throughput single-сell sequencing in cancer research
Qingzhu Jia, Han Chu, Jin Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 103
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 73
The coral microbiome: towards an understanding of the molecular mechanisms of coral–microbiota interactions
Amin R. Mohamed, Michael A. Ochsenkühn, Ahmed M Kazlak, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 55
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 47
Cellular heterogeneity and plasticity in liver cancer
Lo‐Kong Chan, Yu‐Man Tsui, Daniel Wai‐Hung Ho, et al.
Seminars in Cancer Biology (2021) Vol. 82, pp. 134-149
Open Access | Times Cited: 97
A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
Zaoqu Liu, Yuyuan Zhang, Chengcheng Shi, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 85
Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity
Stefano Caruso, Daniel R. O’Brien, Sean P. Cleary, et al.
Hepatology (2020) Vol. 73, Iss. S1, pp. 14-26
Open Access | Times Cited: 79
Integrated multi-omics analysis of ovarian cancer using variational autoencoders
Muta Tah Hira, Mohammad A. Razzaque, Claudio Angione, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 77
Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis
S. Heinrich, Amanda J. Craig, Lichun Ma, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 700-715
Closed Access | Times Cited: 76
Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny
Jianpeng Sheng, Junlei Zhang, Lin Wang, et al.
Gut (2021) Vol. 71, Iss. 6, pp. 1176-1191
Closed Access | Times Cited: 75
Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma
Qianhui Xu, Yuxin Wang, Wen Huang
International Immunopharmacology (2021) Vol. 92, pp. 107333-107333
Closed Access | Times Cited: 74
Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma
Lisha Zhou, Meiling Wang, Hanrui Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 65
The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation
Wenjie Zhang, Guangyan Zhangyuan, Fei Wang, et al.
Immunity (2021) Vol. 54, Iss. 6, pp. 1168-1185.e8
Open Access | Times Cited: 64
The context-specific roles of urea cycle enzymes in tumorigenesis
Emma Hajaj, Marco Sciacovelli, Christian Frezza, et al.
Molecular Cell (2021) Vol. 81, Iss. 18, pp. 3749-3759
Closed Access | Times Cited: 60
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Wantao Wu, Yihan Liu, Shan Zeng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top